Try Ask OE! Our NEW Advanced AI Enabled Search
Dive into the Largest Database of
Musculoskeletal Evidence
ACE Reports.
General Orthopaedics
Efficacy, tolerability and safety of once-monthly administration of 75 mg risedronate in Japanese patients with involutional osteoporosis: A comparison with a 2.5 mg once-daily dosage regimen
Bone. 2014 Feb;59:44-52. doi: 10.1016/j.bone.2013.10.017. Epub 2013 Oct 29.
Efficacy, tolerability and safety of once-monthly administration of 75 mg risedronate in Japanese patients with involutional osteoporosis: A comparison with a 2.5 mg once-daily dosage regimen
This report has been verified by one or more authors of the original publication.
Bone. 2014 Feb;59:44-52. doi: 10.1016/j.bone.2013.10.017. Epub 2013 Oct 29.
Metabolic Disorders
Once-weekly teriparatide reduces vertebral fracture risk: Subgroup analysis from the Teriparatide Once Weekly Efficacy Research (TOWER) trial
Once-weekly teriparatide reduces vertebral fracture risk: Subgroup analysis from the Teriparatide Once Weekly Efficacy Research (TOWER) trial